|
시장보고서
상품코드
2084699
봄철 각결막염 시장 : 약제 종류별, 치료법별, 제형별, 유통 채널별, 지역별Vernal Keratoconjunctivitis Market, By Drug Type, By Treatment, By Dosage Form, By Distribution Channel, By Geography |
||||||
봄철 각결막염 시장은 2026년에 4억 1,400만 달러 규모가 될 것으로 추정되며, 2033년까지 5억 3,030만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 3.6%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 4억 1,400만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 3.60% | 예측 금액(2033년) | 5억 3,030만 달러 |
눈꺼풀 안쪽은 반투명한 조직층인 결막으로 덮여 있습니다. 이 조직이 감염되면 눈의 흰자위를 덮으며, 붉은색이나 분홍색으로 변하는 경향이 있습니다. 따라서 이 안과 질환인 결막염은 흔히 ‘핑크아이’로 알려져 있습니다. 결막염으로 알려진 이 안구 감염증은 이 안과 질환의 일반적인 증상입니다. 감염성 원인에는 세균이나 바이러스의 감염이 포함되며, 비감염성 원인에는 알레르기나 면역매개성 질환에 의한 염증이 포함됩니다. 결막염은 급성 결막염, 초급성 결막염, 만성 결막염으로 분류됩니다.
봄철 각결막염(VKC)은 안구 표면에서 발생하는 만성적이고 다인자성인 Th2 세포 매개 염증성 질환입니다. 윗눈꺼풀 결막과 각막-공막 접합부에 큰 유두가 형성되는 것이 특징입니다. 충혈과 점액성 분비물은 VKC의 전형적인 증상입니다. VKC에 대한 확립된 표준 치료 전략은 없습니다. 치료법으로는 비만세포 안정제, 항히스타민제, 비스테로이드성 항염증제(NSAID), 국소 코르티코스테로이드, 사이클로스포린 등을 사용할 수 있습니다. 치료를 받고 있는 환자의 경우, 눈에 이상이 생기지 않았는지 지속적으로 관찰해야 합니다.
시장 역학
봄철 각결막염에 대한 이해를 높이기 위한 연구 개발(R&D) 활동의 활성화가 예측 기간 동안 전 세계 봄철 각결막염 시장의 성장을 견인할 것으로 예상됩니다. 또한, 봄철 각결막염의 유병률 증가와 지지요법의 보급으로 인해 여러 제약사가 이 질환의 치료법 개발에 관심을 보이고 있습니다. 이 질환의 생물학적 특성과 증상에 대한 이해가 깊어짐에 따라, 개발 중인 치료법이라는 형태로 더 우수한 치료 옵션을 개발하려는 노력이 활발해지고 있으며, 이는 예측 기간 동안 전 세계 봄철 각결막염 시장의 점유율 확대를 뒷받침할 것으로 전망됩니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 봄철 각결막염 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 봄철 각결막염 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 봄철 각결막염 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 봄철 각결막염 시장 : 약제 종류별(2021-2033년)
제5장 세계의 봄철 각결막염 시장 : 치료법별(2021-2033년)
제6장 세계의 봄철 각결막염 시장 : 제형별(2021-2033년)
제7장 세계의 봄철 각결막염 시장 : 유통 채널별(2021-2033년)
제8장 세계의 봄철 각결막염 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 섹션
KSM 26.07.16Vernal Keratoconjunctivitis Market is estimated to be valued at USD 414.0 Mn in 2026 and is expected to reach USD 530.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 414.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.60% | 2033 Value Projection: | USD 530.3 Mn |
The inner surface of the eyelid is lined with conjunctiva, a translucent tissue layer. When infected, this tissue tends to cover the white area of the eye and turn red or pink. As a result, the eye ailment conjunctivitis is often known as pink eye. The infection of the eye known as conjunctivitis is a common symptom of this ophthalmic condition. Infectious causes includes bacterial and viral infections, while non-infectious causes include allergy and immune-mediated illness inflammation. It is categorised into acute conjunctivitis, super acute conjunctivitis, and chronic conjunctivitis.
Vernal keratoconjunctivitis (VKC) is a chronic, multifactorial Th2-cell-mediated inflammatory disease of the ocular surface. It is distinguished by a large papilla on the upper tarsal conjunctiva and a corneoscleral junction. Hyperemia and mucus discharge are typical symptoms of VKC. There is no set standard treatment strategy for VKC. Mast cell stabilisers, antihistamines, nonsteroidal anti-inflammatory medications (NSAIDs), topical corticosteroids, and cyclosporine are available as treatments. Individuals receiving treatment should be continuously observed for the development of any ocular problems.
Market Dynamics
Increasing R&D activities in vernal keratoconjunctivitis for a better understanding of the disease is expected to drive the growth of global vernal keratoconjunctivitis market during the forecast period. In addition, increasing prevalence of vernal keratoconjuctivitis and supportive therapies have built the interest in several pharmaceutical companies in developing a cure for the disease. A greater knowledge of the disease's biology and manifestation of the disease has boosted efforts to develop improved treatment alternatives in the form of pipeline treatments, which is projected to propel the global vernal keratoconjunctivitis market share during the forecast period.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global vernal keratoconjunctivitis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include Santen, Novartis Pharmaceuticals, Senju Pharmaceutical, Allakos, iCo Therapeutics, and Akari Therapeutics.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global vernal keratoconjunctivitis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global vernal keratoconjunctivitis market
Market Segmentation
- By Drug Type (Revenue, USD Mn, 2021-2033)
- Bertilimumab
- Verkazia
- Lodoxamide
- Tacrolimus
- Antolimab
- Nomacopan
- Others
- By Treatment (Revenue, USD Mn, 2021-2033)
- Mast Cell Stabilizers
- Antihistamines
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Topical Corticosteroids
- Cyclosporine
- Tacrolimus
- Others
- By Dosage Form (Revenue, USD Mn, 2021-2033)
- Gel
- Ointment
- Tablet
- Others
- By Distribution Channel (Revenue, USD Mn, 2021-2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Key Players
- Santen
- Novartis Pharmaceuticals
- Senju Pharmaceutical
- Allakos
- iCo Therapeutics
- Akari Therapeutics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Treatment
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Product Approval
- Collaboration/Merge/Acquisition
- Regulatory Landscape
- PEST Analysis
- Porter's Five Forces Analysis
- Epidemiology
- Robust Pipeline Analysis
4. Global Vernal Keratoconjunctivitis Market, By Drug Type, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
- Bertilimumab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Verkazia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Lodoxamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Tacrolimus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Antolimab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Nomacopan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
5. Global Vernal Keratoconjunctivitis Market, By Treatment, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Mast Cell Stabilizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Topical Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Cyclosporine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Tacrolimus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
6. Global Vernal Keratoconjunctivitis Market, By Dosage Form, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Gel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Ointment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
7. Global Vernal Keratoconjunctivitis Market, By Distribution Channel, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Million)
8. Global Vernal Keratoconjunctivitis Market, By Region, 2021 - 2033, (USD Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Million)
- North Africa
- Central Africa
- South Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Company Profile
- Santen
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Novartis Pharmaceuticals
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Senju Pharmaceutical
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Allakos
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- iCo Therapeutics
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Akari Therapeutics
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Santen
- Analyst Views
10. Section
- References
- Research Methodology
- About Us
